Mayo clinic tests antifungal drug for lung mold problem
NCT ID NCT07283497
Summary
This Mayo Clinic study is testing whether itraconazole, an antifungal medication, is a practical and safe treatment option for adults with bronchiectasis who also have mold growing in their airways. The small pilot trial with 30 participants will check if patients can stick with the 6-week treatment and monitor for side effects, while also exploring whether the drug helps respiratory symptoms and changes the mix of microbes in the lungs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.